Institutes unite to put New York on the biopharma map – Nature Medicine News Article
New York is known for doing everything big, with its soaring skyscrapers, throngs of people and huge pizza slices. But the Big Apple has not traditionally been such a big hub for the biopharma industry compared with other places such as San Diego or Boston. The city has tried to remedy that by investing around $26 million dollars in recent years to build or renovate office and lab spaces for life sciences ventures in Manhattan and Brooklyn. But some experts think that the mayoral efforts will not bear fruit until the city’s scientific community gets behind them.
Now, New York’s research institutions have joined the city in an effort to jumpstart biopharma. On 3 November, scientists, investors, and government officials announced the formation of the New York Genome Center (NYGC), a $125 million core facility funded by the city, private groups and 11 founding institutions—all based in the New York area except for the Jackson Laboratory of Bar Harbor, Maine. The new center is slated to open its doors at the end of 2012.
Photo: Kyle McCluer